The Perfect Storm Behind *Nezha 2*'s Blockbuster Success | FreeS Research FreeS Fund
*Nezha 2*: What Its Blockbuster Success Reveals About Culture, Technology, and Investment
峰瑞资本
@freesfund
512 articles
Articles
3/2 Suzhou Offline Event Registration | The 4th Biomedical Innovation and Translation Summit
Exploring the Path of Innovation and Translation in Biomedicine, Together
A Deep Dive into 7 Core Questions About DeepSeek | FreeS Fund Report
In an era of rapid AI advancement, the DeepSeek story is only just beginning.
LimX Dynamics Founder: How Do Intelligent Robots Go From "Usable" to "Productive" to "Profitable"?
The Commercial Challenges and Opportunities of Embodied Intelligence
Here are 13 industry research reports and a podcast episode to get you off to a strong start.
Let's explore the cutting edge and discover new knowledge.
FreeS Fund's 2024 Year in Review: Going Further Together, Doing What's Right Rather Than What's Easy
Thank you to every friend who has journeyed alongside FreeS Fund.
As the year draws to a close, five companies secure new funding to carry momentum into 2025 | FreeS Family Funding News Vol. 21
Looking forward to working alongside more outstanding founders.
2025: Three Directions Where AI Is Reshaping Drug Discovery
How Can AI Help Drug Development Cross the "Valley of Death"?
Li Feng x Guan Qingyou: What New Opportunities Remain in the Consumer Market for 2025?
How should we view the present and future of China's consumer retail market?
eVTOL, China's Next Opportunity to Overtake on the Bend
How do eVTOLs defy gravity, letting us take off like birds at any moment?